Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: A case-control study

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Zuliani, Giovanni ^a,b   Donnorso, Michela P ^c   Bosi, Cristina ^a   Passaro, Angelina ^a   Nora, Edoardo D ^a   Zurlo, Amedeo ^a   Bonetti, Francesco ^a   Mozzi, Alessia F ^c   Cortese, Claudio ^c  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b Associazione Alzheimer Perusini   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

24 HYDROXYCHOLESTEROL; C REACTIVE PROTEIN; CHOLESTEROL DERIVATIVE; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; BIOLOGICAL MARKER; CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; COGNITIVE IMPAIRMENT NO DEMENTIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LATE ONSET ALZHEIMER DISEASE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; ATROPHY; BLOOD; BRAIN; COMPARATIVE STUDY; GENETICS; GENOTYPE; METABOLISM; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; RADIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; ATROPHY; BIOLOGICAL MARKERS; BRAIN; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; DEMENTIA, VASCULAR; FEMALE; GENOTYPE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MILD COGNITIVE IMPAIRMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA;

EID: 80053557887     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-121     Document Type: Article

References (29)

1. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B. Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology 1991, 41:1886-1892.
2. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A. Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study. British Medical Journal 1995, 310:970-973. 2549358, 7728032.
3. Liu Y, Peterson DA, Schubert D. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci USA 1998, 95:13266-71. 10.1073/pnas.95.22.13266, 23777, 9789077.
4. Björkhem I, Meaney S. Brain Cholesterol: Long secret life behind a barrier. Atheroscler Thromb Vasc Biol 2004, 24:806-815.
5. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001, 12:105-112. 10.1097/00041433-200104000-00003, 11264981.
6. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340. 10.1016/S0092-8674(00)80213-5, 9150132.
7. Wolozin B, Brown J, Theisler C, Silberman S. The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev 2004, 10:127-146.
8. Leoni V, Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids 2011, 164(6):515-24. Epub 2011 Apr 16, 10.1016/j.chemphyslip.2011.04.002, 21515244.
9. Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Bjorkhem I, von Bergmann K, Heun R. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002, 36:27-32. 10.1016/S0022-3956(01)00050-4, 11755458.
10. Schonknecht P, Lutjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schroeder J. Cerebrospinal fluid 24-S-hydroxicholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett 2002, 10:83-85.
11. Heverin M, Bogdanovic N. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 2004, 45:186-93.
12. Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Randi DO, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000, 451:195-98.
13. Bretillon L, Siden A, Wahlung LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett 2000, 293:87-90. 10.1016/S0304-3940(00)01466-X, 11027840.
14. Kolsch H, Heun R, Kerksiek A, Bergmann KV, Maier W, Lütjohann D. Altered levels of plasma 24S-hydroxycholesterol in demented patients. Neurosci Lett 2004, 368:303-8. 10.1016/j.neulet.2004.07.031, 15364416.
15. Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard AR, Julin P, Svenson L, Wahlund LO, Andreasen N, Winblad B, Soininen H, Björkhem I. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci Lett 2009, 462:89-93. 10.1016/j.neulet.2009.06.073, 19560513.
16. Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Molecular Psychiatry 2002, 7:899-902. 10.1038/sj.mp.4001109, 12232784.
17. Sauder S, Kölsch H, Lütjohann D, Schulz A, von Bergmann K, Maier W, Heun R. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. J Neural Transm 2005, 112:1381-9. 10.1007/s00702-004-0267-z, 15666037.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical Diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Ofman A, Moody MD, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata Y, Kokmen E, Bermejo F, Wolf PA, Gorelich PB, Bich KL, Pajeau AK, Bell MA, De Carli C, Culebras A, Korczyn AD, Bogouslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research study. Neurology 1993, 43:250-260.
20. Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Blè A, Fellin R. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res 2007, 41:686-693. 10.1016/j.jpsychires.2006.02.008, 16600299.
21. DeBarber AE, Lutjohann D, Merkens L, Steiner RD. Liquid chromatography tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. Anal Biochem 2008, 381:151-3. 10.1016/j.ab.2008.05.037, 2562163, 18555788.
22. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor gamma (PPARgamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997, 18:270-4.
23. Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem 2004, 279:34674-81. 10.1074/jbc.M402324200, 15148325.
24. Elovaara I, Palo J, Erkinjuntti T, Sulkava R. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Eur Neurol 1987, 26:229-234. 10.1159/000116341, 3595662.
25. Bjorkhem J. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006, 260:493-508. 10.1111/j.1365-2796.2006.01725.x, 17116000.
26. Alexandrov P. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Molecular Neuroscience 2005, 9:909-913.
27. Ferrè P. The biology of peroxisome proliferator-activated receptors. relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53:S43-50. 10.2337/diabetes.53.2007.S43, 14749265.
28. Carantoni M, Zuliani G, Munari MR, D'Elia K, Palmieri E, Fellin R. Alzheimer and vascular dementia: relationships with fasting glucose and insulin levels. Dem Geriatric Cogn Dis 2000, 11:176-180.
29. Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia. Arch Neurol 2007, 64:103-107. 10.1001/archneur.64.1.103, 17210816.